BTBP
60016112.830.00% ( 0.00 )
BTBP (600161)
Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and marketing of blood products in China and internati...
- Open
- 12.71
- High
- 12.83
- Low
- 12.65
- Prev. Close
- 12.83
- Volume
- 124.98K
- Turnover
- 159.22M
- Avg Price
- 12.74
- Bid/Ask Ratio
- --
- Amplitude
- 1.40%
- 52wk High
- 21.88
- Volume Ratio
- 0.55
- Turnover Ratio
- 0.63%
BTBP Analyst Rating
View MoreForecast & Rating
Jul 15, 2026Price forecast
¥18.7045.75%
Forecast & RatingBuy
4analysts
- Strong buy25.00%
- Buy50.00%
- Hold25.00%
- Sell0.00%
- Strong sell0.00%
News
- 同壁财经 · Jun 2 at 09:10 PM
BTBP has continuously received a Wind ESG A rating, with a comprehensive score of 7.02
- Zhitong · Oct 24, 2025 at 04:29 AM
BTBP: Reviewed the third quarterly report, adjusted the structure, and acquired 1% equity in Songzi Pulp Station
- Zhitong · Oct 21, 2025 at 04:34 AM
BTBP: Recently officially launched Phase III clinical trials for human prothrombin complex
- Zhitong · Sep 30, 2025 at 04:23 AM
BTBP: Tiantan Kunming has been approved to conduct clinical trials for "human fibrinogen"
- Zhitong · Sep 22, 2025 at 05:17 AM
BTBP's subsidiary received a notice of compliance inspection for drug GMP
- Zhitong · Sep 18, 2025 at 02:57 AM
Beijing BTBP 2025 Half-Year Equity Distribution Implementation Announcement Released
